These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465 [TBL] [Abstract][Full Text] [Related]
23. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors. Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788 [TBL] [Abstract][Full Text] [Related]
24. Are Elevated Serum Triglycerides Really a Risk Factor for Coronary Artery Disease? Reiner Ž Cardiology; 2015; 131(4):225-7. PubMed ID: 25968652 [No Abstract] [Full Text] [Related]
25. What role does HDL cholesterol have in CVD and what is the most effective way to increase it? Marcason W J Am Diet Assoc; 2011 Aug; 111(8):1266. PubMed ID: 21802575 [No Abstract] [Full Text] [Related]
26. Metabolic effects of nandrolone decanoate and resistance training in men with HIV. Sattler FR; Schroeder ET; Dube MP; Jaque SV; Martinez C; Blanche PJ; Azen S; Krauss RM Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1214-22. PubMed ID: 12388173 [TBL] [Abstract][Full Text] [Related]
27. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Amarenco P; Goldstein LB; Callahan A; Sillesen H; Hennerici MG; O'Neill BJ; Rudolph AE; Simunovic L; Zivin JA; Welch KM; Atherosclerosis; 2009 Jun; 204(2):515-20. PubMed ID: 18962621 [TBL] [Abstract][Full Text] [Related]
28. Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids. Reinehr T; Kiess W; Andler W Metabolism; 2005 Mar; 54(3):397-402. PubMed ID: 15736120 [TBL] [Abstract][Full Text] [Related]
29. The Editor's Roundtable: the metabolic syndrome. Friedewald VE; Grundy S; Gotto AM; Haffner S; Denke MA; Hollander P; Roberts WC Am J Cardiol; 2007 Feb; 99(3):382-9. PubMed ID: 17261403 [No Abstract] [Full Text] [Related]
30. [Cardiovascular disease-related serum lipid parameters in a Hungarian subpopulation]. Szépvölgyi J; Kravják BE; Bíró L; Nagy K; Bíró G; Antal M Orv Hetil; 1997 Aug; 138(32):2005-8. PubMed ID: 9297170 [TBL] [Abstract][Full Text] [Related]
31. What does the future hold for niacin as a treatment for hyperlipidaemia and cardiovascular disease? Ahmed MH J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):858-60. PubMed ID: 20686417 [TBL] [Abstract][Full Text] [Related]
32. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women. dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250 [TBL] [Abstract][Full Text] [Related]
33. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity. Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423 [TBL] [Abstract][Full Text] [Related]
34. The association of apolipoprotein B and low density lipoprotein with cardiovascular risk factors in the Thai population. Krittayaphong R; Chotinaiwatarakul C; Kangkagate C; Bhuripanyo K; Mahanonda N J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S1-7. PubMed ID: 17722296 [TBL] [Abstract][Full Text] [Related]
35. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada. Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ; Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578 [TBL] [Abstract][Full Text] [Related]
36. Metabolic basis of low high density lipoprotein in subjects with impaired glucose tolerance. Pietzsch J; Julius U; Hanefeld M Ann N Y Acad Sci; 1999 Nov; 892():323-6. PubMed ID: 10842675 [No Abstract] [Full Text] [Related]
37. Effect of interleukin-3 on lipoprotein(a) and lipoprotein cholesterol levels. Massé J Am J Cardiol; 1995 Oct; 76(10):747. PubMed ID: 7572647 [No Abstract] [Full Text] [Related]
38. From remnant cholesterol to lipoprotein(a) - emerging risk factors for cardiovascular diseases beyond low density lipoprotein. Mukherjee D; Mikhailidis DP Curr Opin Cardiol; 2024 Jul; 39(4):279. PubMed ID: 38832818 [No Abstract] [Full Text] [Related]